Trials / Completed
CompletedNCT02107131
Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab
Evaluation of ReAding Speed, Contrast Sensitivity, and Work Productivity in Working Individuals With Diabetic Macular Edema Following Treatment With Intravitreal Ranibizumab
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- California Retina Consultants · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Performance assessment testing may be a useful tool to evaluate the impact of ranibizumab on day-to-day visual function in patients with Diabetic Macular Edema (DME).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravitreal ranibizumab 0.3mg |
Timeline
- Start date
- 2015-03-13
- Primary completion
- 2017-05-15
- Completion
- 2017-05-15
- First posted
- 2014-04-08
- Last updated
- 2018-12-19
- Results posted
- 2018-12-19
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02107131. Inclusion in this directory is not an endorsement.